These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15016326)

  • 1. Analysis of CD8 T-cell response by IFNgamma ELISPOT and H-2L(d)/pRL1a tetramer assays in pRL1a multiple antigen peptide-immunized and RL male 1-bearing BALB/c and (BALB/c x C57BL/6) F(1) mice.
    Takada I; Noguchi Y; Kenjo A; Wada H; Uenaka A; Fujita T; Inoue H; Nakayama E
    Cancer Sci; 2004 Mar; 95(3):254-9. PubMed ID: 15016326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occurrence of tumor antigen pRL1a specific CD8 T cells in spleen cells from syngeneic BALB/c, semiallogeneic (BALB/c x C57BL/6)F1 and allogeneic C57BL/6 mice.
    Hata H; Uenaka A; Takada I; Kenjo A; Takahashi M; Ono T; Fujita T; Nakayama E
    Int J Oncol; 2002 May; 20(5):1019-25. PubMed ID: 11956599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination with multiple antigen peptide as rejection antigen peptide in murine leukemia.
    Manki A; Ono T; Uenaka A; Seino Y; Nakayama E
    Cancer Res; 1998 May; 58(9):1960-4. PubMed ID: 9581839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a CD4 T-cell epitope in tumor rejection antigen RLakt on BALB/c radiation-leukemia RL male 1.
    Kaya S; Uenaka A; Sato S; Ono T; Aji T; Nakayama E
    Cancer Sci; 2008 Jul; 99(7):1441-7. PubMed ID: 18452555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine leukemia RL male 1 and sarcoma Meth A antigens recognized by cytotoxic T lymphocytes (CTL).
    Uenaka A; Nakayama E
    Cancer Sci; 2003 Nov; 94(11):931-6. PubMed ID: 14611667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diversity of epitopes recognized by cytotoxic T lymphocytes that are specific for rejection antigen peptide pRL1a presented on BALB/c leukemia RL Male 1.
    Yokoi T; Uenaka A; Ono T; Onizuka S; Inoue H; Nakayama E
    Int Immunol; 1997 Aug; 9(8):1195-201. PubMed ID: 9263017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of multiple unique rejection antigens on murine leukemia BALB/c RLmale symbol1 and the role of dominant Akt antigen for tumor escape.
    Matsuo M; Wada H; Honda S; Tawara I; Uenaka A; Kanematsu T; Nakayama E
    J Immunol; 1999 Jun; 162(11):6420-5. PubMed ID: 10352255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible involvement of autoreactive CD4 T cells in generation of cytotoxic T lymphocytes on in vitro stimulation with H-2 class I-binding tumor antigen peptide.
    Honda S; Wada H; Uenaka A; Nakayama E
    Int Immunol; 1998 Aug; 10(8):1167-74. PubMed ID: 9723703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of murine leukemia RLmale1 rejection antigen peptide pRL1a by proteolysis of natural precursor pRL1b.
    Ono T; Uenaka A; Nakayama E
    Jpn J Cancer Res; 1996 Nov; 87(11):1165-70. PubMed ID: 9045946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular processing of a multibranched lysine core with tumor antigen peptides and presentation of peptide epitopes recognized by cytotoxic T lymphocytes on antigen-presenting cells.
    Ota S; Ono T; Morita A; Uenaka A; Harada M; Nakayama E
    Cancer Res; 2002 Mar; 62(5):1471-6. PubMed ID: 11888922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of RL male 1 tumor growth in BALB/c mice by introduction of the RLakt gene coding for antigen recognized by cytotoxic T-lymphocytes and the GM-CSF gene by in vivo electroporation.
    Tanaka M; Yamada M; Ono T; Noguchi Y; Uenaka A; Ota S; Hata H; Harada M; Tanimoto M; Nakayama E
    Cancer Sci; 2004 Feb; 95(2):154-9. PubMed ID: 14965366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide pool immunization and CD8+ T cell reactivity.
    Rasmussen SB; Harndahl MN; Stryhn A; Buus S; Claesson MH
    Immunol Lett; 2013 Mar; 151(1-2):48-53. PubMed ID: 23499579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a unique antigen peptide pRL1 on BALB/c RL male 1 leukemia recognized by cytotoxic T lymphocytes and its relation to the Akt oncogene.
    Uenaka A; Ono T; Akisawa T; Wada H; Yasuda T; Nakayama E
    J Exp Med; 1994 Nov; 180(5):1599-607. PubMed ID: 7964448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Culture filtrate specific H-2(b) restricted CD8+ T cells activated in vivo by Mycobacterium tuberculosis or bovis BCG recognize a restricted number of immunodominant peptides.
    Denis O; Stroobant V; Colau D; D'Souza S; Huygen K
    Immunol Lett; 2002 Apr; 81(2):115-24. PubMed ID: 11852116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel H-2D
    McAuliffe J; Panetti S; Steffke E; Wicki A; Pereira-Almeida V; Noblecourt L; Hu Y; Guo SYW; Lesenfants J; Ramirez-Valdez RA; Chandrasekar V; Ahmad M; Stroobant V; Vigneron N; Van den Eynde BJ; Leung CSK
    J Immunother Cancer; 2024 Oct; 12(10):. PubMed ID: 39384196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Definition of a unique cell surface antigen of mouse leukemia RL male 1 by cell-mediated cytotoxicity.
    Nakayama E; Shiku H; Takahashi T; Oettgen HF; Old LJ
    Proc Natl Acad Sci U S A; 1979 Jul; 76(7):3486-90. PubMed ID: 91166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous assessment of antigen-stimulated cytokine production and memory subset composition of memory CD8 T cells.
    Jabbari A; Harty JT
    J Immunol Methods; 2006 Jun; 313(1-2):161-8. PubMed ID: 16762359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitation of CD8+ T cell expansion, memory, and protective immunity after immunization with peptide-coated dendritic cells.
    Hamilton SE; Harty JT
    J Immunol; 2002 Nov; 169(9):4936-44. PubMed ID: 12391206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNF-mediated toxicity after massive induction of specific CD8+ T cells following immunization of mice with a tumor-specific peptide.
    Bilsborough J; Uyttenhove C; Colau D; Bousso P; Libert C; Weynand B; Boon T; van den Eynde BJ
    J Immunol; 2002 Sep; 169(6):3053-60. PubMed ID: 12218121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow-microfluorometric monitoring of oligoclonal CD8+ T cell responses to an immunodominant Moloney leukemia virus-encoded epitope in vivo.
    Brawand P; Biasi G; Horvath C; Cerottini JC; MacDonald HR
    J Immunol; 1998 Feb; 160(4):1659-65. PubMed ID: 9469422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.